These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 35734982)

  • 21. Germline Genetic Features of Young Individuals With Colorectal Cancer.
    Stoffel EM; Koeppe E; Everett J; Ulintz P; Kiel M; Osborne J; Williams L; Hanson K; Gruber SB; Rozek LS
    Gastroenterology; 2018 Mar; 154(4):897-905.e1. PubMed ID: 29146522
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic testing for inherited colorectal cancer and polyposis, 2021 revision: a technical standard of the American College of Medical Genetics and Genomics (ACMG).
    Mao R; Krautscheid P; Graham RP; Ganguly A; Shankar S; Ferber M; Hegde M;
    Genet Med; 2021 Oct; 23(10):1807-1817. PubMed ID: 34140662
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High frequency of pathogenic non-founder germline mutations in
    Maksimenko J; Irmejs A; Trofimovičs G; Bērziņa D; Skuja E; Purkalne G; Miklaševičs E; Gardovskis J
    Hered Cancer Clin Pract; 2018; 16():12. PubMed ID: 29928469
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Implementation of massive sequencing in the genetic diagnosis of hereditary cancer syndromes: diagnostic performance in the Hereditary Cancer Programme of the Valencia Community (FamCan-NGS).
    Ramírez-Calvo M; García-Casado Z; Fernández-Serra A; de Juan I; Palanca S; Oltra S; Soto JL; Castillejo A; Barbera VM; Juan-Fita MJ; Segura Á; Chirivella I; Sánchez AB; Tena I; Chaparro C; Salas D; López-Guerrero JA
    Hered Cancer Clin Pract; 2019; 17():3. PubMed ID: 30675318
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations.
    Vysotskaia V; Kaseniit KE; Bucheit L; Ready K; Price K; Johansen Taber K
    Cancer; 2020 Feb; 126(3):549-558. PubMed ID: 31682005
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence and spectrum of pathogenic variants among patients with multiple primary cancers evaluated by clinical characteristics.
    Bychkovsky BL; Lo MT; Yussuf A; Horton C; Richardson M; LaDuca H; Garber JE; Rana HQ
    Cancer; 2022 Mar; 128(6):1275-1283. PubMed ID: 34875721
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Investigating the prevalence of pathogenic variants in Saudi Arabian patients with familial cancer using a multigene next generation sequencing panel.
    AlHarbi M; Mobark NA; AlJabarat WAR; ElBardis H; AlSolme E; Hamdan AB; AlFakeeh AH; AlMushawah F; AlHarthi F; AlSharm AA; Balbaid AAO; AlJohani N; Zhou AY; Robinson HA; Alqahtani SA; Abedalthagafi M
    Oncotarget; 2023 Jun; 14():580-594. PubMed ID: 37306523
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A comprehensive custom panel evaluation for routine hereditary cancer testing: improving the yield of germline mutation detection.
    Velázquez C; Lastra E; Avila Cobos F; Abella L; de la Cruz V; Hernando BA; Hernández L; Martínez N; Infante M; Durán M
    J Transl Med; 2020 Jun; 18(1):232. PubMed ID: 32522261
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline whole genome sequencing in adults with multiple primary tumors.
    Wang Y; Ding Q; Prokopec S; Farncombe KM; Bruce J; Casalino S; McCuaig J; Szybowska M; van Engelen K; Lerner-Ellis J; Pugh TJ; Kim RH
    Fam Cancer; 2023 Oct; 22(4):513-520. PubMed ID: 37481477
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel Pathogenic Variants in Hereditary Cancer Syndromes in a Highly Heterogeneous Cohort of Patients: Insights from Multigene Analysis.
    Bilyalov A; Danishevich A; Nikolaev S; Vorobyov N; Abramov I; Pismennaya E; Terehova S; Kosilova Y; Primak A; Stanoevich U; Lisica T; Shipulin G; Gamayunov S; Kolesnikova E; Khatkov I; Gusev O; Bodunova N
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201513
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translation into Turkish of: "Changes to publication requirements made at the XVIII International Botanical Congress in Melbourne - what does e-publication mean for you?". Translated by Ali A. Dönmez, Yusuf Menemen and Zübeyde Uğurlu. "Onsekizinci (XVIII) Uluslararası Botanik Kongresi'nde (Melbourne) Yayın ile I˙lgili Gereklilikler Konusunda Yapılan Değişiklikler; e-yayın size ne ifade ediyor".
    Knapp S; McNeill J; Turland NJ
    PhytoKeys; 2011; (7):49-56. PubMed ID: 38515617
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Recommendations for Preventive Care for Women with Rare Genetic Cause of Breast and Ovarian Cancer.
    Foretová L; Navrátilová M; Svoboda M; Vašíčková P; Sťahlová EH; Házová J; Kleiblová P; Kleibl Z; Macháčková E; Palácová M; Petráková K
    Klin Onkol; 2019; 32(Supplementum2):6-13. PubMed ID: 31409076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterozygous Pathogenic Nonsense Variant in the
    Guadagnolo D; Mastromoro G; Marchionni E; Germani A; Libi F; Sadeghi S; Savio C; Petrucci S; De Marchis L; Piane M; Pizzuti A
    Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509701
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New Perspectives on the Recurrent Monoallelic Germline Mutations of DNA Repair and Checkpoint Genes and Clinical Variability.
    Sahin I; Saat H
    Genet Test Mol Biomarkers; 2022 Jan; 26(1):17-25. PubMed ID: 35089076
    [No Abstract]   [Full Text] [Related]  

  • 35. Genetic Characterization of Hereditary Cancer Syndromes Based on Targeted Next-Generation Sequencing.
    Ercoskun P; Yuce Kahraman C; Ozkan G; Tatar A
    Mol Syndromol; 2022 Feb; 13(2):123-131. PubMed ID: 35418818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.
    Slavin TP; Niell-Swiller M; Solomon I; Nehoray B; Rybak C; Blazer KR; Weitzel JN
    Front Oncol; 2015; 5():208. PubMed ID: 26484312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inherited Cancer Susceptibility Gene Sequence Variations Among Patients With Appendix Cancer.
    Holowatyj AN; Washington MK; Tavtigian SV; Eng C; Horton C
    JAMA Oncol; 2022 Nov; 9(1):95-101. PubMed ID: 36368039
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of AlphaFold structure-based protein stability prediction on missense variations in cancer.
    Keskin Karakoyun H; Yüksel ŞK; Amanoglu I; Naserikhojasteh L; Yeşilyurt A; Yakıcıer C; Timuçin E; Akyerli CB
    Front Genet; 2023; 14():1052383. PubMed ID: 36896237
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pancreatic Cancer with Mutation in BRCA1/2, MLH1, and APC Genes: Phenotype Correlation and Detection of a Novel Germline BRCA2 Mutation.
    Vietri MT; D'Elia G; Caliendo G; Albanese L; Signoriello G; Napoli C; Molinari AM
    Genes (Basel); 2022 Feb; 13(2):. PubMed ID: 35205366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Splicing profile by capture RNA-seq identifies pathogenic germline variants in tumor suppressor genes.
    Landrith T; Li B; Cass AA; Conner BR; LaDuca H; McKenna DB; Maxwell KN; Domchek S; Morman NA; Heinlen C; Wham D; Koptiuch C; Vagher J; Rivera R; Bunnell A; Patel G; Geurts JL; Depas MM; Gaonkar S; Pirzadeh-Miller S; Krukenberg R; Seidel M; Pilarski R; Farmer M; Pyrtel K; Milliron K; Lee J; Hoodfar E; Nathan D; Ganzak AC; Wu S; Vuong H; Xu D; Arulmoli A; Parra M; Hoang L; Molparia B; Fennessy M; Fox S; Charpentier S; Burdette J; Pesaran T; Profato J; Smith B; Haynes G; Dalton E; Crandall JR; Baxter R; Lu HM; Tippin-Davis B; Elliott A; Chao E; Karam R
    NPJ Precis Oncol; 2020; 4():4. PubMed ID: 32133419
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.